DEVELOPMENTAL
AND BEHAVIORAL PEDIATRICS*
*See
also Society for
Developmental Pediatrics Program
Saturday, May 4, 2002
9:15am-12:00pm
Mini Course
4010
Long-Term Effects of Childhood Cancer
Chair: Smita Bhatia, City
of Hope National Medical Center, Duarte, CA
This mini-course will address
several of the major topics of interest relating to the
long-term health status and psychosocial functioning of
individuals diagnosed and treated for cancer during
childhood and adolescence. Topics to be presented
include endocrinologic sequelae, risk of subsequent
malignancies, psychosocial late-effects, and
educational/intervention strategies.
Overview
Smita Bhatia, City of Hope National Medical Center,
Duarte, CA
Second and Subsequent Malignancies Among Survivors of
Childhood Cancer
Smita Bhatia, City of Hope National Medical Center,
Duarte, CA
Educational Intervention Strategies Among Childhood
Cancer Survivors
Melissa Hudson, St. Jude Children's Research
Hospital, Memphis, TN
Psychosocial Function of Childhood Cancer Survivors
Daniel Armstrong, University of Miami School of
Medicine, Miami, FL
Endocrinologic Late Effect Among Survivors of
Childhood and Adolescent Cancers
Charles A. Sklar, Memorial Sloan-Kettering Cancer
Center, New York, NY
Sponsored jointly with the American Society of
Pediatric Hematology/Oncology
9:15am-12:00pm
Mini Course
4011
Stem Cell Transplantation
Chair: Nancy Bunin,
Children's Hospital of Philadelphia, Philadelphia, PA
This mini course will provide
participants with an update on both the current status
and future of stem cell transplant in pediatrics. Both
malignant and non-malignant diseases will be addressed.
Advances in graft engineering have made many of these
advances possible, and this will be discussed in an
overview of autologous stem cell transplant for solid
tumors. Allogeneic stem cell transplant may be curative
for some patients with hemoglobinopathies and metabolic
diseases. Non-myeloablative approaches to
hemoglobinopathies are a relatively novel approach,
which may be curative without some of the short and
long-term toxicities of a myeloablative regimen.
Disease-specific characteristics that impact upon
transplant outcome of patients with inherited metabolic
storage disorders will be identified and discussed.
Finally, the concepts of mesenchymal cell transplant and
the future of mesenchymal cell transplant therapy will
be summarized and discussed.
Introduction
Nancy Bunin, Children's Hospital of Philadelphia,
Philadelphia, PA
Tandem Transplantation for High-Risk Pediatric
Malignancies
Stephan Grupp, The Children's Hospital of
Philadelphia, Philadelphia, PA
Reducing the Toxicity of Stem Cell Transplantation
for Hemoglobinopathies
Robert Iannone, The Children's Hospital of
Philadelphia, Philadelphia, PA
Stem Cell Transplantation for Selected Inherited
Metabolic Diseases: The Mucopolysaccharidoses and the
Leukodystrophies
Charles Peters, University of Minnesota Medical
School, Minneapolis, MN
Future Horizons in Stem Cell Transplantation: The
Quest to Conquer Non-Hematopoietic Disease
Edwin Horwitz, St. Jude Children's Research
Hospital, Memphis, TN
Discussion
Sponsored jointly with the American Society of
Pediatric Hematology/Oncology
12:00pm-3:00pm
Mini Course
4101
Genetics for the Pediatrician: The Intersection of
General Pediatrics and Genetics
Chairs: Benjamin Siegel,
Boston University School of Medicine, Boston Medical
Center, Boston, MA and Jeff Milunsky, Boston University
School of Medicine, Boston Medical Center, Boston, MA
Approaches to the diagnosis,
management, and discussion of the psychosocial, legal
and ethical issues of genetics, from screening, to
giving bad news, to helping families understand and cope
with the impact of genetic diseases within a family
context, have always been challenges for the general
pediatrician. There are new technologies in the genetic
testing of children and family members that expand our
ability to accurately diagnose, provide anticipatory
guidance and genetic counseling to individuals and
parents, so that they may make more informed
reproductive choices. It is clear that pediatricians and
clinical geneticists need to work collaboratively as a
team to provide the most comprehensive care possible.
This session will examine the information needed from
the clinical assessment of the child, in relationship to
the family context that increases the likelihood that
the pediatrician is dealing with a possible genetic
issue. Exploration of the history, including the family
pedigree, aspects of the physical exam that alerts the
pediatrician to a possible genetic problem, the referral
process to a clinical geneticist, and the legal,
ethical, and psychosocial issues that should be
addressed with the individual or family member before
the referral to the geneticist will be presented. The
process of the clinical genetic evaluation will be
explored, highlighting the ethical, legal and
psychosocial issues. Current and newer genetic
technologies will be reviewed. The collaborative process
between the patient/family, the pediatrician, and
geneticist will be examined.
Overview
Benjamin S. Siegel, Boston University School of
Medicine, Boston Medical Center, Boston, MA
The Approach to the Genetic Evaluation of a Child
with a Suspected Genetic Disorder and the Use of Current
and Newer Genetic Technologies
Jeff M. Milunsky, Boston University School of
Medicine, Boston Medical Center, Boston, MA
Break
The Referral Process to a Clinical Geneticist: A General
Pediatric Perspective
Benjamin S. Siegel, Boston University School of
Medicine, Boston Medical Center, Boston, MA
The Ethical, Legal and Social Issues of Clinical
Genetics
Benjamin S. Siegel, Boston University School of
Medicine, Boston Medical Center, Boston, MA
12:00pm-3:00pm
Mini Course
4103
Sports Participation by Chronically Ill Children and
Adolescents: Let the Games Begin!
Chair: Dilip Patel,
Michigan State University, Kalamazoo Center for Medical
Studies, Kalamazoo, MI
This mini course will focus on
helping children and adolescents with chronic illness
take full part in sports play (competitive and
non-competitive). The role of sports in the lives of our
children has become increasingly important in the
enhancement of their development. A variety of illnesses
will be reviewed in this perspective, with emphasis on
diabetes mellitus, asthma and developmental
disabilities. Questions from the audience will be
sought. The course will be taught by a sports medicine
pediatrician, a pediatric endocrinologist and a
neurodevelopmental specialist.
Chronic Disease and Sports
Dilip R. Patel, Michigan State University, Kalamazoo
Center for Medical Studies, Kalamazoo, MI
Diabetes and Sports
Martin B. Draznin, Michigan State University,
Kalamazoo Center for Medical Studies, Kalamazoo, MI
Developmental Disabilities and Sports
Patricia A. Newhouse, Michigan State University,
Kalamazoo Center for Medical Studies, Kalamazoo, MI
1:00pm-3:00pm
Poster Symposium
4182
Historical Perspectives
Chairs: Thor Willy Hansen
and James Kendig
3:15pm-5:15pm
Topic Symposium
4200
Cloning and Embryonic Stem Cells
Chair: Judith Hall,
University of British Columbia, Vancouver, Canada
There is enormous public
interest in cloning and embryonic stem cells. This
symposium will update the pediatric community on recent
developments and raises a variety of policy and ethical
issues.
Overview
Judith G. Hall, University of British Columbia,
Vancouver, Canada
Imprinting and Reprogramming
Arthur L. Beaudet, Baylor College of Medicine,
Houston, TX
Cloning
Brigid Hogan, Vanderbilt University Medical Center
and the Howard Hughes Medical Institute, Nashville, TN
Embryonic Stem Cells
Janet Rossant, Samuel Lunenfeld Research Institute,
Mount Sinai Hospital ON, Canada
3:15pm-5:15pm
Topic Symposium
4202
Stroke in Childhood
Chair: Donna Ferriero,
University of California, San Francisco, CA
This session will update
physicians on epidemiology and risk factors for
perinatal and childhood stroke. Emphasis will be placed
on identifying risk factors, increasing recognition, and
providing possibilities for treatment.
Biologic Mechanisms of Stroke
Valina Dawson, Johns Hopkins Medical Institutions,
Baltimore, MD
Epidemiology of Perinatal Stroke
Karin Nelson, National Institute of Neurological
Disorders and Stroke, Bethesda, MD
Childhood Stroke
Gabrielle deVeber, Hospital for Sick Children,
Toronto, Canada
Imaging in Childhood Stroke
Linda S. de Vries, Wilhelmina Children's Hospital,
UMCU, The Netherlands
Sponsored jointly with the American Society of
Pediatric Hematology/Oncology and the Pediatric Academic
Societies
This symposium is dedicated to the memory of Dr. Maureen
Andrew
3:15pm-5:15pm
Platform Session
4251
Behavioral Pediatrics I
Chairs: Daniel Lee Coury
and Ronald V. Marino
5:15pm-7:15pm
Poster Session I (Author Attended)
and Opening Reception
–
Behavioral Pediatrics
Sunday, May 5, 2002
8:00am-10:00am
Platform Session
5050
Behavioral Pediatrics II
Chairs: Robin L. Hansen and
Marsha D. Rappley
8:00am-10:00am
Platform Session
5051
General Pediatrics I
Chairs: Benjamin Gitterman
and Linda Diane Meloy
8:00am-11:00am
Mini Course
5090
Adolescent Medicine - Part II—Eating Disorders
Chair: Donald E. Greydanus,
Michigan State University, Kalamazoo, MI
This presentation will present
an overview of the research on the diagnosis,
assessment, and treatment (therapy: including
psychological and pharmacological; settings: inpatient,
day treatment, and outpatient) of adolescents with
eating disorders. A brief comparison of the diagnostic
criteria used by the American Psychiatric Association
and the World Health Organization will be presented and
discussed regarding the relevance to research design and
diagnosis. Special issues (such as research design,
subject selection, research settings, geographical
location, definitions, terminology, race and culture,
managed care, and reimbursement) and their impact on our
current knowledge base and on treatment choices will be
addressed. Recommendations for future directions in
assessment, treatment, and research will be offered.
Overview
Donald E. Greydanus, Michigan State University
College of Human Medicine, Kalamazoo, MI
Diagnostic Criteria: American Psychiatric
Association, World Health Organization, Implications for
Diagnosing Adolescents
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Special Issues: Subject Selection: Gender, Race,
Ethnicity, Sexual Orientation
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Research Design: Research/Treatment Settings,
Inpatient, Day Treatment, Outpatient, Hospital, Clinic,
Community, Geographical Location, Definitions,
Disorders, Recovery
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Break
Treatment Interventions: Psychological, Psycho-pharmacologic
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Treatment Outcomes
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Recommendations for Future Research
Helen D. Pratt, Michigan State University, Center
for Medical Studies, Kalamazoo, MI
Discussion
8:00am-11:00am
Workshops
5104
Developmental and Cultural Concepts: Children's and
Parents' Understanding of Illness
Numerous studies document
systematic developmental stages and cultural differences
in how children and adults understand physical and
psychological conditions. These developmental and
cultural differences are related to families’ health
seeking behaviors and coping strategies. They are
important to the recognition of symptoms, the
understanding of diagnoses, and compliance with
appropriate treatments.
In this interactive workshop, a panel of
investigators will briefly present research findings
from developmental psychology and pediatrics and medical
anthropology that inform clinical work with children and
adults across ages and cultural contexts. The panel will
include, in addition to ourselves, David Schonfeld, Lee
Pachter and Pradeep Gidwani whose research addresses
AIDS, cancer, asthma and ADHD among other conditions.
Videotaped interviews and role-plays will highlight key
concepts and guide a discussion of methods to improve
communications with families by integrating this body of
research into clinical interactions. Break-out groups,
led by each member of panel, will follow to discuss the
clinical implications of this research and to develop
ideas for future research.
J. M. McMenamy, E. C. Perrin, Center for Children
with Special Needs, Department of Pediatrics, Tufts
University/New England Medical Center, Boston, MA
8:00am-11:00am
Special Interest Groups
5110
Complementary and Alternative Pediatrics
The Complementary and Alternative Pediatrics SIG will present two speakers, followed by planning for the creation of a web-based pediatric database / curriculum in Integrative Pediatrics. Sharon McDonough-Means, M.D., one of the first two graduates of the Integrative Pediatrics Fellowship of the University of
Arizona, will speak on “An Integrative Approach to Attention Deficit Hyperactivity Disorder Treatment: Evidence – Based Strategies.” The next speaker will be the SIG’s co-leader, Sharon Riesen, M.D., Associate Professor of Pediatrics at Loma Linda University. She will speak about “Glyconutrients in the Treatment of Asthma: A Spoonful of Sugar is the Medicine Going Down.” The third hour of the SIG will be used to consider the creation of an Integrative Pediatric Database and Curriculum accessible via the Internet. Please join us for this exploration of alternative approaches to some common pediatric problems and the ensuing discussion and planning period.
Cochairs: Scott Faber, sfaber@mercy.pmhs.org,
and Sharon Riesen, sriesen@ahs.llumc.edu
5115
Practice-Based Research Networks
Chair: Richard Pan, r.pan@ucdmc.ucdavis.edu
12:00pm-1:30pm
Alliance Club
5300A
Perinatal Brain Club
The Use of Cranial Ultrasound and
Advanced Magnetic Resonance Imaging Techniques in the
Understanding and Detection of Neonatal Brain Injury
Linda S. de Vries, Wilhelmina
Children's Hospital, UMCU, The Netherlands
Petra S. Huppi, Children's Hospital, University of
Geneva, Geneva, Switzerland
Terrie E. Inder
1:45pm-2:30pm
State of the Art Plenary
5590
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Chairs: Phyllis Dennery,
Stanford University School of Medicine, Palo Alto, CA
and Tina Lee Cheng, Johns Hopkins University School of
Medicine, Baltimore, MD
With the recent world events
and new threats of biowarfare, what should pediatricians
know? Due to their size and physiology, children are at
higher risk of injury from bioterrorism. This session
will address the biology, clinical manifestations, and
possible preventive strategies for likely biowarfare
agents. The unique vulnerability of the child will be
addressed.
Overview
Phyllis A. Dennery, Stanford University School of
Medicine, Palo Alto, CA
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Ralph D. Feigin, Baylor College of Medicine,
Houston, TX
Discussion
2:00pm
– 5:00pm
Special Interest Group
5610
Behavioral
Pediatrics
This
year's Behavioral Pediatrics SIG will focus on the
pediatrician's role in working with a variety of family
issues beyond straightforward behavior management and
medications. Our
presenters will be Dr. William Coleman of the Department
of Pediatrics at the University of North Carolina, and
Dr. Barbara Howard of Johns Hopkins School of Medicine
in Baltimore. Their topic is Behavioral Interactional
Problems: Family Systems Techniques.
Problems such as parent-child conflict,
child/parent depression, sleep problems, and
social-emotional complications of ADHD will be addressed
with a family-oriented approach that views problems and
solutions within the family context in which they arise.
The family is the physician's great resource.
Participants will learn to: 1) identify problems
suitable for family counseling; 2) interview families;
3) assess family functioning; 4) help families adapt and
develop their own solutions; and 5) deal with
disappointment and failure.
Teaching methods include case studies,
interactive discussions, an extensive syllabus, videos
of family interviews and a live first-time unrehearsed
interview with a real family referred by a local
pediatrician.
There
will also be a brief business meeting to discuss updates
on board certification and residency and fellowship
training issues.
For further information contact Dan Coury at dcoury@chi.osu.edu.
Chair: Dan Coury, Dcoury@chi.osu.edu
2:00pm-4:00pm
State of the Art Plenary
5701
Children as Research Subjects: Ethical and Regulatory
Issues
Chair: Myron Genel, Yale
University School of Medicine, New Haven, CT
A number of highly publicized
adverse events, including the death of two volunteers
participating in non-therapeutic research, and the
federal shutdown of research at many well-recognized
academic institutions because of inadequate compliance
with regulatory requirements have intensified scrutiny
of the protection afforded to human subjects
participating in research, including children.
Furthermore a Maryland court has recently decreed that
children cannot participate in research without the
potential for direct benefit. As a consequence there has
been increasing media attention and Congressional
concern regarding the adequacy of institutional
oversight and investigator attentiveness to established
standards and regulations. In addition, new regulations
issued under the Health Insurance Portability and
Accountability Act of l996(HIPAA) threaten the capacity
to conduct health services and outcomes research. These
issues will be addressed in the 9th annual Public Policy
Plenary Symposium in an interactive format intended to
stimulate dialogue among the members of the panel and
with the audience.
Overview
Myron Genel, Yale University School of Medicine, New
Haven, CT
Overseeing Research in Children: New Concerns and New
Regulations
Alan R. Fleischman, The New York Academy of
Medicine, New York, NY
International Health Research: Where Bioethics,
Politics and Economics Converge
Eric M. Meslin, Indiana University Center for
Bioethics, Indianapolis, IN
Compliance: What You and Your Institution Need to
Know (and Do)
Pearl O'Rourke, Partners HealthCare System, Inc.,
Boston, MA
HIPAA, Privacy & Confidentiality and Research In
Children?
Brian Kamoie, The George Washington University,
Washington, DC
Discussion
Sponsored jointly with the Public Policy Council
of the APS, AMSPDC, SPR and the Public Policy Committee
of the APA
Supported in part by an educational grant from Columbus
Children's Hospital
2:00pm-5:00pm
Workshops
5608
Pediatric Obesity: Practical Evaluation and Treatment
Strategies for Primary Care Providers
The United States is
experiencing an epidemic of pediatric obesity. However,
many primary care providers report that obesity is one
of the most frustrating and difficult problems in their
practices. In this workshop, we will provide practical
strategies for evaluating and treating obese children in
primary care. To maximize learning and relevance the
session will be split. Approximately one-third of the
session will focus on expert committee recommendations
for evaluation and behavioral treatment strategies. We
will address skills for identification of obesity,
screening for both rare endogenous causes of obesity and
more common obesity-associated conditions or risk
factors, assessment of emotional and psychosocial
states, eating and activity assessment, and indications
for consultation with an obesity specialist. For
treatment, we will address the most successful
strategies for diet and physical activity counseling,
changing the household environment, self-monitoring,
goal setting and contracting, parenting skills training,
maintenance and relapse prevention, and the potential
role of drug therapies. The other two-thirds of the
session will consist of case discussions and group
problem solving. Cases will address practical evaluation
and management challenges facing primary care providers.
T. N. Robinson and S. E. Barlow, Dept. of Pediatrics,
Stanford University, Palo Alto, CA, and Dept. of
Pediatrics, St. Louis University School of Medicine, St.
Louis, MO
2:00pm-5:00pm
Special Interest Group
5610
Behavioral Pediatrics
Chair: Dan Coury, Dcoury@chi.osu.edu
2:30pm-4:00pm
State of the Art Plenary
5702
Developmental Biology and Pediatrics
Chair: David H. Rowitch,
Harvard Medical School, Dana-Farber Cancer Institute,
Boston, MA
Basic studies of developmental
biology can have profound implications for child health
and disease. In this State of the Art Plenary Plenary,
pediatric investigators at the forefront of basic
science will describe recent advances in our
understanding of development of the central nervous
system, heart and blood with implications for the
pathophysiology of congenital malformations, acquired
disease and pediatric cancer.
Hedgehog Signaling in CNS Development and
Tumorigenesis
David H. Rowitch, Harvard Medical School,
Dana-Farber Cancer Institute, Boston, MA
Molecular Pathways of Cardiac Development and
Congenital Heart Disease
Deepak Srivastava, The University of Texas
Southwestern Medical Center, Dallas, TX
Molecular Control of Hematopoietic Cell Lineage
Stuart H. Orkin, Dana Farber Cancer Institute,
Boston, MA
2:30pm-4:00pm
State of the Art Plenary
5703
Insulin Resistance Syndromes
Chairs: Alan Rogol, Insmed
Pharmaceuticals, Inc., Glen Allen, VA and Charlotte
Boney, Rhode Island Hospital, Providence, RI
Insulin resistance is the
underlying factor in many of the consequences of obesity
in childhood and adolescence, including ovarian
hyperandrogenism, hypertension, hyperlipidemia, and Type
2 diabetes. Obesity, dyslipidemia, and Type 2 diabetes
are components of SyndromeX in adults, a serious public
health issue. In addition, insulin has a role in the
regulation of leptin, the major signal of adiposity to
the brain. Dr. Arslanian will discuss insulin resistance
in polycystic ovary disease and Type 2 diabetes. Dr.
Freedman will review the cardiac risk factors related to
insulin resistance, and Dr. Roemmich will discuss the
insulin-leptin axis in obesity and puberty.
Insulin Resistance: It's Not for Adults Only
Silva A. Arslanian, Children's Hospital of
Pittsburgh, Pittsburgh, PA
Clustering of Coronary Heart Disease Risk Factors in
Obese Children
David Freedman, Division of Nutrition and Physical
Activity, Centers for Disease Control, Atlanta, GA
The Insulin-Leptin Axis in Puberty
James Roemmich, School of Medicine and Biomedical
Sciences, University of Buffalo, Buffalo, NY
Sponsored jointly with the Lawson Wilkins Pediatric
Endocrine Society and the American Academy of Pediatrics
4:15pm-6:15pm
Topic Symposium
5800
End-of-Life Palliative Care
Chair: Marcia Levetown,
Independent Pain and Palliative Care Consultant,
Houston, TX
53,000 children die annually
in the United States and many more live with chronic,
life-threatening conditions. Yet, pediatric education
and subspecialty training do not currently prepare
practitioners to care for these needy children, their
parents, community and survivors. This symposium,
presented by a pediatric hematologist/oncologist,
pediatric palliative care physician and a bereaved
parent, will discuss how to incorporate palliative care
into pediatric care. Specific highlights are the
presentation of an integrated model of care, beginning
at the time of diagnosis of a potentially
life-threatening condition, parental and patient
perspectives on the fight against disabling symptoms and
death, and the ethics behind the decision-making process
that confronts the family and medical care team.
Overview
Marcia Levetown, Independent Pain and Palliative
Care Consultant, Houston, TX
Incorporating Pediatric Palliative Care Principles
into Oncology Care from the Time of Diagnosis
Joanne Hilden, The Cleveland Clinic Foundation,
Cleveland, OH
Community Resources for Pediatric Palliative Care
Sue Huff, Center for Hospice and Palliative Care,
Cheektowaga, NY
The Value of a Day in the Life of a Terminally Ill
Child
Jan Wheeler, Ed. D Candidate, University of Houston,
Houston, TX. Bereaved Mother
Ethical Issues in Medical Decision-Making: When the
Patient is a Child
Marcia Levetown, Independent Pain and Palliative
Care Consultant, Houston, TX
Sponsored jointly with the American Society of
Pediatric Hematology/Oncology
4:15pm-6:15pm
Platform Session
5901
Brain Imaging
Chair: William D. Gaillard
4:15pm-6:15pm
Poster Symposium
5906
Neonatal Epidemiology and Follow-Up
Chairs: Mark A. Klebanoff
and Saroj Saigal
Monday, May 6, 2002
8:00am-10:00am
Topic Symposium
6000
Human Brain Imaging: Insights into Development and
Plasticity
Chairs: Sherin U. Devaskar,
University of California, Los Angeles, CA and Joseph J.
Volpe, Boston Children's Hospital, Harvard Medical
School, Boston, MA
State-of-the-art imaging of
the human brain has been achieved by advances in
magnetic resonance imaging (MRI) and positron emission
tomography (PET). Recent work with MRI and PET has
provided remarkable insights into the structure and the
function of the brain of infants and children during
normal development and with plasticity. In this session,
reviews of the insights obtained with such techniques as
3D-volumetric and diffusion tensor MRI, functional MRI,
and PET-based studies of brain receptors and metabolism
will be presented by leaders in the field. Emphasis will
be on the most recent findings, including considerable
unpublished work.
Introductory Overview
Joseph J. Volpe, Children's Hospital, Harvard
Medical School, Boston, MA
PET Studies of Human Brain Development,
Impoverishment and Plasticity
Harry T. Chugani, Children's Hospital of Michigan,
Wayne State University School of Medicine, Detroit, MI
3-D Volumetric and Diffusion Tensor MRI to Assess
Brain Development and Plasticity
Petra S. Huppi, Children's Hospital, University of
Geneva, Geneva, Switzerland
The Use of fMRI in Developmental Neuroimaging
Michael Rivkin, Boston Children's Hospital, Harvard
Medical School, Boston, MA
8:00am-10:00am
Platform Session
6059
Underserved Populations I
Chairs: Carrie L. Byington
and Charles Feild
9:00am-12:00pm
Workshops
6105
Early Identification and Assessment of Children with an
Autism Spectrum Disorder
Pediatricians play a crucial
role in identifying infants and toddlers who may have
significant developmental needs. Recently, there has
been a growing concern about possible increases in the
numbers of children with an autism spectrum disorder (ASD).
Early identification and intervention can significantly
improve the long-term outcome for these children and
their families. Unfortunately, although symptoms of the
ASDs are generally present before 3 years of age, the
average diagnosis is not made until 4.5 years of age.
Given the unusual patterns of development shown by
children with autism in communication, social, and
behavioral skills, parents often report frustration
associated with trying to identify the nature of their
child’s needs and with accessing appropriate services.
Pediatricians can provide helpful screening and
diagnostic referral information. The aim of this
workshop is to provide information about the early signs
of children with an ASD, to identify screening
instruments for the ASDs and to describe the referral
process in case further assessment and intervention are
warranted. Workshop activities will include presentation
and discussion, video observation of children with and
without ASDs and small group evaluations of clinical
vignettes profiling a child in need of more detailed
developmental assessment. The goal is to help
pediatricians implement guidelines recently established
for identifying children with an ASD by the American
Academy of Pediatrics.
C. E. Rice, O. Y. Ousley*, and M. Yeargin-Allsopp,
National Center on Birth Defects and Developmental
Disabilities, Centers for Disease Control and Prevention
and *Emory University Department of Psychiatry, Atlanta,
GA
10:15am-12:15pm
Platform Session
6201
Emergency Medicine—Psychiatric/General
Chairs: Jane F. Knapp and
Linda Quan
10:15am-12:15pm
Platform Session
6203
Neurodevelopmental Disabilities I: Prenatal and
Postnatal Influences on Developmental Outcome
Chairs: Herbert J. Cohen
and Philip S. Zeskind
10:15am-12:15pm
Platform Session
6204
Underserved Populations II
Chairs: Paul L. McCarthy
and Ronald C. Samuels
1:30pm-5:30pm
APA Presidential Plenary
6450
APA Presidential Plenary and Armstrong Lecture
Chair: Steve Ludwig
The George Armstrong
Lecture
Steven A. Schroeder
Ray E. Helfer Award for Innovation in Pediatric
Education: Measuring Medical Knowledge Competencies
Using Web-Enhanced Instruction During a Pediatric
Resident Ambulatory Block Month
Carl E. Johnson
Larry C. Hurtubise
International Health Award: Clinical Presentation,
Immediate Outcome and Prognostic Factors of Cerebral
Malaria in Children Admitted to Mulago Hospital
Richard Idro
Distinguished Career Award
Barbara Starfield
2:45pm-4:45pm
Platform Session
6552
Clinical Bioethics
Chairs: Susan Hintz and Jon
E. Tyson
2:45pm-4:45pm
Platform Session
6556
Mechanisms of Brain Injury
Chair: John D. E. Barks
6:45pm-9:45pm
Alliance Society
6710A
Society for Developmental Pediatrics
Developmental Outcomes After
Reproductive Technologies: Relevance to Fetal Origins of
Disease
Germaine Buck
Advances in Neuroprotection: From Animal Models to
Clinical Trials
Rebecca Ichord
Tuesday, May 7, 2002
8:00am-10:00am
Topic Symposium
7000
Advances in Autism: Etiology, Imaging and Treatment
Chair: Daniel Coury,
Children's Hospital, Columbus, OH
The autistic spectrum
disorders have received increased attention from the
public and research communities over the past decade.
Theories regarding the possible etiology of the
disorder, techniques for better evaluating and
diagnosing persons displaying symptoms, and
evidence-based treatment options have all received
attention. Panel members will present the latest
thinking regarding these issues and discuss
controversial findings that have confused clinicians and
families.
Introduction
Daniel Lee Coury, Children's Hospital, Columbus, OH
Newborn Biologic Markers for Autism
Judith Grether, California Department of Health
Services, Oakland, CA
Neuroimaging in Autism
Pauline A. Filipek, University of California, Irvine
College of Medicine, Orange, CA
Alternative Biologic Treatments
Susan E. Levy, Children's Seashore House of the
Children's Hospital, Philadelphia, PA
Effectiveness of Behavioral Therapy
James Mulick, Columbus Children's Hospital,
Columbus, OH
8:00am-10:00am
Platform Session
7061
Underserved Populations III
Chairs: Jay H. Mayefsky and
John I. Takayama
10:00am-11:45am
State of the Art Plenary
7200
Pediatric Pain
Chairs: K. J. S. Anand,
Arkansas Children's Hospital, Little Rock, AR and R.
Whit Hall, University of Arkansas for Medical Sciences,
Little Rock, AR
Critical periods for early
brain development are associated with neurogenesis,
neuronal migration, exuberant synaptogenesis, and
developmental regulation of cell differentiation and
apoptosis. Exposure to repetitive or prolonged pain
during critical windows in development can permanently
alter the neural substrates associated with pain
processing as well as other behavioral domains. This
symposium will describe age related changes in pain
processing, recent advances in analgesic pharmacology
for pediatric patients, and the long-term effects of
neonatal pain on subsequent cognition and behavior.
Translational research applied to pain processing and
analgesic management will be emphasized, to provide the
practicing pediatrician with the scientific rationale
for current clinical practice.
Introduction and an Overview of Pediatric Pain
Research
K. J. S. Anand, Arkansas Children's Hospital and
University of Arkansas for Medical Science, Little Rock,
AR
R. Whit Hall, University of Arkansas for Medical
Sciences, Little Rock, AR
Repetitive Neonatal Pain: Long-Term Effects in Human
Infants?
Ruth Eckstein Grunau, University of British
Columbia, Vancouver, Canada
Advances in Pediatric Analgesic Pharmacology for the
Management of Acute and Chronic Pain
Charles Berde, Children's Hopsital, Boston, MA
Managing the Pain of Emergency Procedures: Sedation,
Schizophrenia and Senility
David M. Jaffe, Washington University School of
Medicine, St. Louis Children's Hospital, St. Louis, MO
Pain, Plasticity, and Preterm Birth: Findings From
the Bench and Bedside
K. J. S. Anand, Arkansas Children's Hospital and
University of Arkansas for Medical Science, Little Rock,
AR
Conclusions
R. Whit Hall, University of Arkansas for Medical
Sciences, Little Rock, AR
12:00pm-1:30pm
Poster Session
Behavioral Pediatrics
General Pediatrics and Preventive Pediatrics
1:45pm-3:30pm
Platform Session
7804
Neurodevelopmental Disabilities II: Autism, ADHD and
Neuroimaging
Chairs: Ronald L. Lindsay
and Nancy J. Roizen
1:45pm-3:45pm
Hot Topic
7700
Models for Building Mental Health Capacity in Pediatric
Primary Care
Chair: Anne M. Gadomski,
The Mary Imogene Bassett Research Institute,
Cooperstown, NY
This session will describe
three models presently under study for building the
capacity of pediatric primary care sites to manage
children’s mental health problems. Two models are
based on enhancements or extra resources for primary
care providers, and the third is based on primary
providers' skills.
Speakers will describe ongoing research, present
interim data, and outline replicable interventions.
Following the presentations there will be an opportunity
for questions and discussion.
Overview
Anne M. Gadomski, Bassett Healthcare, Cooperstown,
NY
Building and Maintaining a Therapeutic Alliance in
Pediatric Primary Care
Lawrence Wissow, Johns Hopkins School of Public
Health, Baltimore, MD
Promoting Evidence-Based ADHD Treatment Among
Pediatricians
Jeff Epstein, Duke University Medical Center,
Durham, NC
Youth Partners in Care: A Quality Improvement Model
for Primary Care Treatment of Adolescent Depression
Lisa Jaycox, RAND, Arlington, VA
Discussion
1:45pm-3:45pm
Hot Topic
7702
Disaster Preparedness: Beyond 9/11
Chairs: Tina L. Cheng,
Johns Hopkins University School of Medicine, Baltimore,
MD; Danelle Laraque, Mount Sinai School of Medicine, New
York, NY; and Benard Dreyer, New York, NY
The impact of 9/11 and the
public health aftermath have affected us personally and
professionally. This session will address what the child
health professional needs to know regarding disaster
planning and preparedness. Speakers will review and
provide updates on national and regional systems for
emergency management and how those systems interact with
local public health agencies, the pediatrician's role in
the community's preparedness including what the school
system, the pediatric office and the patient should be
doing to prepare and respond, recognition and management
of chemical and biologic agents of terrorism, and the
psychological reactions to disaster and stress.
Disaster Planning and Preparedness for Child Health
Professionals
George L. Foltin, New York University School of
Medicine and Bellevue Hospital Center, New York, NY
Biologic Agents of Terrorism
Anne Fine, New York City Department of Health, New
York, NY
Chemical Agents of Terrorism
Fred Henretig, University of Pennsylvania School of
Medicine and Children's Hospital of Philadelphia,
Philadelphia, PA
Helping Children Cope with Terrorism and Disasters
David J. Schonfeld, Yale University School of
Medicine, New Haven, CT
Discussion
1:45pm-3:45pm
Platform Session
7805
Underserved Populations IV
Chairs: Thomas G. DeWitt
and Victoria Meguid
|
